Rchr
J-GLOBAL ID:201401097973208731   Update date: Apr. 18, 2024

Sanada Yu

Sanada Yu
Affiliation and department:
Research field  (1): Molecular biology
Research theme for competitive and other funds  (3):
  • 2019 - 2023 二重特異性抗体を用いたBNCTホウ素デリバリーシステムの開発
  • 2019 - 2023 Interrelationship analysis of the characteristics of quiescent tumor cells with tumor heterogeneity and cancer stem cell nature, referring to application to cancer therapy
  • 2015 - 2018 An attempt to achieve both controlling local tumors and repressing distant metastases through exploiting analytical findings concerning characteristics of intratumor microenvironment
Papers (27):
  • Riku Kawasaki, Ayano Oshige, Keita Yamana, Hidetoshi Hirano, Kotaro Nishimura, Yamato Miura, Ryuji Yorioka, Yu Sanada, Kaori Bando, Anri Tabata, et al. HER-2-targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction. Chemistry (Weinheim an der Bergstrasse, Germany). 2023. e202302486
  • Davide Perico, Ying Tong, Lichao Chen, Shoji Imamichi, Yu Sanada, Masamichi Ishiai, Minoru Suzuki, Mitsuko Masutani, Pierluigi Mauri. Proteomic Characterization of SAS Cell-Derived Extracellular Vesicles in Relation to Both BPA and Neutron Irradiation Doses. Cells. 2023. 12. 12
  • Riku Kawasaki, Hidetoshi Hirano, Keita Yamana, Ayano Oshige, Kotaro Nishimura, Nanami Kono, Yu Sanada, Kaori Bando, Anri Tabata, Naoki Yasukawa, et al. Phospholipid-Coated Boronic Oxide Nanoparticles as a Boron Agent for Boron Neutron Capture Therapy. ChemBioChem. 2023
  • Davide Perico, Dario Di Silvestre, Shoji Imamichi, Yu Sanada, Mitsuko Masutani, Pier Luigi Mauri. Systems Biology Approach to Investigate Biomarkers, Boron-10 Carriers, and Mechanisms Useful for Improving Boron Neutron Capture Therapy. Cancer biotherapy & radiopharmaceuticals. 2023. 38. 3. 152-159
  • Shin-Ichiro Masunaga, Yu Sanada, Takushi Takata, Hiroki Tanaka, Yoshinori Sakurai, Minoru Suzuki, Mitsunori Kirihata, Koji Ono. The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy. Journal of radiation research. 2023. 64. 2. 399-411
more...
MISC (74):
  • TONG Ying, CHEN Lichao, CHEN Lichao, GAO Zhongming, IMAMICHI Shoji, IMAMICHI Shoji, IMAMICHI Shoji, SANADA Yu, SASAKI Yuka, NOZAKAI Tadashige, et al. The role of GM-CSF in the early response to BNCT. 日本分子生物学会年会プログラム・要旨集(Web). 2023. 46th
  • GAO Zhongming, TONG Ying, IMAMICHI Shoji, IMAMICHI Shoji, IMAMICHI Shoji, SANADA Yu, SUZUKI Minoru, 石合正道, 石合正道, MASUNAGA Shinichiro, et al. The biological analysis of noncoding RNA SNHG12 after boron neutron capture therapy (BNCT). 日本癌学会学術総会抄録集(Web). 2023. 82nd
  • 真田悠生, 高田卓志, 田中浩基, 櫻井良憲, 渡邉翼. Attempts to enhance the anti-tumor effects of BNCT by targeting the tumor microenvironment. KURNS-EKR (Web). 2023. 17
  • 河崎陸, 平野英寿, 山名啓太, 真田悠生, 坂東香里, 田畑杏梨, 櫻井良憲, 田中浩基, 鈴木実, 澤田晋一, et al. Development of Hybrid Nanogels with Highly Integrated Boron Oxide Nanoparticle and Evaluation of Their Biofunction. ホスト-ゲスト・超分子化学シンポジウム講演要旨集. 2023. 20th
  • 真田悠生, 渡邉翼. Recent biological studies for boron neutron capture therapy (BNCT). 放射線生物研究. 2023. 58. 2
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page